Deep learning models have proven to be effective on medical datasets for accurate diagnostic predictions from images. However, medical datasets often contain noisy, mislabeled, or poorly generalizable images, particularly for edge cases and anomalous outcomes. Additionally, high quality datasets are often small in sample size that can result in overfitting, where models memorize noise rather than learn generalizable patterns. This in particular, could pose serious risks in medical diagnostics where the risk associated with mis-classification can impact human life. Several data-efficient training strategies have emerged to address these constraints. In particular, coreset selection identifies compact subsets of the most representative samples, enabling training that approximates full-dataset performance while reducing computational overhead. On the other hand, curriculum learning relies on gradually increasing training difficulty and accelerating convergence. However, developing a generalizable difficulty ranking mechanism that works across diverse domains, datasets, and models while reducing the computational tasks and remains challenging. In this paper, we introduce Iterative Misclassification Error Training (IMET), a novel framework inspired by curriculum learning and coreset selection. The IMET approach is aimed to identify misclassified samples in order to streamline the training process, while prioritizing the model's attention to edge case senarious and rare outcomes. The paper evaluates IMET's performance on benchmark medical image classification datasets against state-of-the-art ResNet architectures. The results demonstrating IMET's potential for enhancing model robustness and accuracy in medical image analysis are also presented in the paper.

Accurate stratification of the activity index of Crohn's disease (CD) using computed tomography enterography (CTE) radiomics and serum markers can aid in predicting disease progression and assist physicians in personalizing therapeutic regimens for patients with CD. This retrospective study enrolled 233 patients diagnosed with CD between January 2019 and August 2024. Patients were divided into training and testing cohorts at a ratio of 7:3 and further categorized into remission, mild active phase, and moderate-severe active phase groups based on simple endoscopic score for CD (SEC-CD). Radiomics features were extracted from CTE venous images, and T-test and least absolute shrinkage and selection operator (LASSO) regression were applied for feature selection. The serum markers were selected based on the variance analysis. We also developed a random forest (RF) model for multi-class stratification of CD. The model performance was evaluated by the area under the receiver operating characteristic curve (AUC) and quantified the contribution of each feature in the dataset to CD activity via Shapley additive exPlanations (SHAP) values. Finally, we enrolled gender, radiomics scores, and serum scores to develop a nomogram model to verify the effectiveness of feature extraction. 14 non-zero coefficient radiomics features and six serum markers with significant differences (P<0.01) were ultimately selected to predict CD activity. The AUC (micro/macro) for the ensemble machine learning model combining the radiomics features and serum markers is 0.931/0.928 for three-class. The AUC for the remission phase, the mild active phase, and the moderate-severe active phase were 0.983, 0.852, and 0.917, respectively. The mean AUC for the nomogram model was 0.940. A radiomics model was developed by integrating radiomics and serum markers of CD patients, achieving enhanced consistency with SEC-CD in grade CD. This model has the potential to assist clinicians in accurate diagnosis and treatment.

As technological innovation in computers has advanced, radiologists may now diagnose brain tumors (BT) with the use of artificial intelligence (AI). In the medical field, early disease identification enables further therapies, where the use of AI systems is essential for time and money savings. The difficulties presented by various forms of Magnetic Resonance (MR) imaging for BT detection are frequently not addressed by conventional techniques. To get around frequent problems with traditional tumor detection approaches, deep learning techniques have been expanded. Thus, for BT segmentation utilizing MR images, a U-Net-based architecture combined with Attention Mechanisms has been developed in this work. Moreover, by fine-tuning essential variables, Hyperparameter Optimization (HPO) is used using the Bayesian Optimization Algorithm to strengthen the segmentation model's performance. Tumor regions are pinpointed for segmentation using Region-Adaptive Thresholding technique, and the segmentation results are validated against ground truth annotated images to assess the performance of the suggested model. Experiments are conducted using the LGG, Healthcare, and BraTS 2021 MRI brain tumor datasets. Lastly, the importance of the suggested model has been demonstrated through comparing several metrics, such as IoU, accuracy, and DICE Score, with current state-of-the-art methods. The U-Net-based method gained a higher DICE score of 0.89687 in the segmentation of MRI-BT.

This research aimed to compare the classification accuracy of three machine learning (ML) methods (random forest (RF), support vector machines (SVM), linear discriminant analysis (LDA)) for sex estimation of sub-adults using cranial computed tomography (CCT) images. A total of 521 CCT scans from sub-adult Malaysians aged 0 to 20 were analysed using Mimics software (Materialise Mimics Ver. 21). Plane-to-plane (PTP) protocol was used for measuring 14 chosen craniometric parameters. A trio of machine learning algorithms RF, SVM, and LDA with GridSearchCV was used to produce classification models for sex estimation. In addition, performance was measured in the form of accuracy, precision, recall, and F1-score, among others. RF produced testing accuracy of 73%, with the best hyperparameters of max_depth = 6, max_samples = 40, and n_estimators = 45. SVM obtained an accuracy of 67% with the best hyperparameters: learning rate (C) = 10, gamma = 0.01, and kernel = radial basis function (RBF). LDA obtained the lowest accuracy of 65% with shrinkage of 0.02. Among the tested ML methods, RF showed the highest testing accuracy in comparison to SVM and LDA. This is the first AI-based classification model that can be used for estimating sex in sub-adults using CCT scans.

Precise delineation of brain tissues, including lesions, in MR images is crucial for data analysis and objectively assessing conditions like neurological disorders and brain tumors. Existing methods for tissue segmentation often fall short in addressing patients with lesions, particularly those with brain tumors. This study aimed to develop and evaluate a robust pipeline utilizing convolutional neural networks for rapid and automatic segmentation of whole brain tissues, including tumor lesions. The proposed pipeline was developed using BraTS'21 data (1251 patients) and tested on local hospital data (100 patients). Ground truth masks for lesions as well as brain tissues were generated. Two convolutional neural networks based on deep residual U-Net framework were trained for segmenting brain tissues and tumor lesions. The performance of the pipeline was evaluated on independent test data using dice similarity coefficient (DSC) and volume similarity (VS). The proposed pipeline achieved a mean DSC of 0.84 and a mean VS of 0.93 on the BraTS'21 test data set. On the local hospital test data set, it attained a mean DSC of 0.78 and a mean VS of 0.91. The proposed pipeline also generated satisfactory masks in cases where the SPM12 software performed inadequately. The proposed pipeline offers a reliable and automatic solution for segmenting brain tissues and tumor lesions in MR images. Its adaptability makes it a valuable tool for both research and clinical applications, potentially streamlining workflows and enhancing the precision of analyses in neurological and oncological studies.

&#xD;Radiotherapy (RT) has become increasingly sophisticated, necessitating advanced tools for analyzing extensive treatment data in hospital databases. Such analyses can enhance future treatments, particularly through Knowledge-Based Planning, and aid in developing new treatment modalities like convergent kV RT.&#xD;Purpose: The objective is to develop automated software tools for large-scale retrospective analysis of over 10,000 MeV x-ray radiotherapy plans. This aims to identify trends and references in plans delivered at our institution across all treatment sites, focusing on: (A) Planning-Target-Volume, Clinical-Target-Volume, Gross-Tumor-Volume, and Organ-At-Risk (PTV/CTV/GTV/OAR) topology, morphology, and dosimetry, and (B) RT plan efficiency and complexity.&#xD;Methods:&#xD;The software tools are coded in Python. Topological metrics are evaluated using principal component analysis, including center of mass, volume, size, and depth. Morphology is quantified using Hounsfield Units, while dose distribution is characterized by conformity and homogeneity indexes. The total dose within the target versus the body is defined as the Dose Balance Index. &#xD;Results:&#xD;The primary outcome of this study is the toolkit and an analysis of our database. For example, the mean minimum and maximum PTV depths are about 2.5±2.3 cm and 9±3 cm, respectively.&#xD;Conclusions:&#xD;This study provides a statistical basis for RT plans and the necessary tools to generate them. It aids in selecting plans for knowledge-based models and deep-learning networks. The site-specific volume and depth results help identify the limitations and opportunities of current and future treatment modalities, in our case convergent kV RT. The compiled statistics and tools are versatile for training, quality assurance, comparing plans from different periods or institutions, and establishing guidelines. The toolkit is publicly available at https://github.com/m-kinz/STAR.

This study proposes Scout-Dose-TCM for direct, prospective estimation of organ-level doses under tube current modulation (TCM) and compares its performance to two established methods. We analyzed contrast-enhanced chest-abdomen-pelvis CT scans from 130 adults (120 kVp, TCM). Reference doses for six organs (lungs, kidneys, liver, pancreas, bladder, spleen) were calculated using MC-GPU and TotalSegmentator. Based on these, we trained Scout-Dose-TCM, a deep learning model that predicts organ doses corresponding to discrete cosine transform (DCT) basis functions, enabling real-time estimates for any TCM profile. The model combines a feature learning module that extracts contextual information from lateral and frontal scouts and scan range with a dose learning module that output DCT-based dose estimates. A customized loss function incorporated the DCT formulation during training. For comparison, we implemented size-specific dose estimation per AAPM TG 204 (Global CTDIvol) and its organ-level TCM-adapted version (Organ CTDIvol). A 5-fold cross-validation assessed generalizability by comparing mean absolute percentage dose errors and r-squared correlations with benchmark doses. Average absolute percentage errors were 13% (Global CTDIvol), 9% (Organ CTDIvol), and 7% (Scout-Dose-TCM), with bladder showing the largest discrepancies (15%, 13%, and 9%). Statistical tests confirmed Scout-Dose-TCM significantly reduced errors vs. Global CTDIvol across most organs and improved over Organ CTDIvol for the liver, bladder, and pancreas. It also achieved higher r-squared values, indicating stronger agreement with Monte Carlo benchmarks. Scout-Dose-TCM outperformed Global CTDIvol and was comparable to or better than Organ CTDIvol, without requiring organ segmentations at inference, demonstrating its promise as a tool for prospective organ-level dose estimation in CT.

Brain plays a crucial role in regulating body functions and cognitive processes, with brain tumors posing significant risks to human health. Precise and prompt detection is a key factor in proper treatment and better patient outcomes. Traditional methods for detecting brain tumors, that include biopsies, MRI, and CT scans often face challenges due to their high costs and the need for specialized medical expertise. Recent developments in machine learning (ML) and deep learning (DL) has exhibited strong capabilities in automating the identification and categorization of brain tumors from medical images, especially MRI scans. However, these classical ML models have limitations, such as high computational demands, the need for large datasets, and long training times, which hinder their accessibility and efficiency. Our research uses MobileNET model for efficient detection of these tumors. The novelty of this project lies in building an accurate tumor detection model which use less computing re-sources and runs in less time followed by efficient decision making through the use of image processing technique for accurate results. The suggested method attained an average accuracy of 98.5%.

Ultrasound (US) is widely accessible and radiation-free but has a steep learning curve due to its dynamic nature and non-standard imaging planes. Additionally, the constant need to shift focus between the US screen and the patient poses a challenge. To address these issues, we integrate deep learning (DL)-based semantic segmentation for real-time (RT) automated kidney volumetric measurements, which are essential for clinical assessment but are traditionally time-consuming and prone to fatigue. This automation allows clinicians to concentrate on image interpretation rather than manual measurements. Complementing DL, augmented reality (AR) enhances the usability of US by projecting the display directly into the clinician's field of view, improving ergonomics and reducing the cognitive load associated with screen-to-patient transitions. Two AR-DL-assisted US pipelines on HoloLens-2 are proposed: one streams directly via the application programming interface for a wireless setup, while the other supports any US device with video output for broader accessibility. We evaluate RT feasibility and accuracy using the Open Kidney Dataset and open-source segmentation models (nnU-Net, Segmenter, YOLO with MedSAM and LiteMedSAM). Our open-source GitHub pipeline includes model implementations, measurement algorithms, and a Wi-Fi-based streaming solution, enhancing US training and diagnostics, especially in point-of-care settings.

Deep learning (DL) methods are increasingly outperforming classical approaches in brain imaging, yet their generalizability across diverse imaging cohorts remains inadequately assessed. As age and sex are key neurobiological markers in clinical neuroscience, influencing brain structure and disease risk, this study evaluates three of the existing three-dimensional architectures, namely Simple Fully Connected Network (SFCN), DenseNet, and Shifted Window (Swin) Transformers, for age and sex prediction using T1-weighted MRI from four independent cohorts: UK Biobank (UKB, n=47,390), Dallas Lifespan Brain Study (DLBS, n=132), Parkinson's Progression Markers Initiative (PPMI, n=108 healthy controls), and Information eXtraction from Images (IXI, n=319). We found that SFCN consistently outperformed more complex architectures with AUC of 1.00 [1.00-1.00] in UKB (internal test set) and 0.85-0.91 in external test sets for sex classification. For the age prediction task, SFCN demonstrated a mean absolute error (MAE) of 2.66 (r=0.89) in UKB and 4.98-5.81 (r=0.55-0.70) across external datasets. Pairwise DeLong and Wilcoxon signed-rank tests with Bonferroni corrections confirmed SFCN's superiority over Swin Transformer across most cohorts (p<0.017, for three comparisons). Explainability analysis further demonstrates the regional consistency of model attention across cohorts and specific to each task. Our findings reveal that simpler convolutional networks outperform the denser and more complex attention-based DL architectures in brain image analysis by demonstrating better generalizability across different datasets.